Abstract:Autosomal dominant polycystic kidney disease is the most common monogenic cause of ESKD. Genetic studies from patients and animal models have informed disease pathobiology and strongly support a "threshold model" in which cyst formation is triggered by reduced functional polycystin dosage below a critical threshold within individual tubular epithelial cells due to (1) germline and somatic PKD1 and/or PKD2 mutations, (2) mutations of genes (e.g., SEC63, SEC61B, GANAB, PRKCSH, DNAJB11, ALG8, and ALG9) in the endoplasmic reticulum protein biosynthetic pathway, or (3) somatic mosaicism. Genetic testing has the potential to provide diagnostic and prognostic information in cystic kidney disease. However, mutation screening of PKD1 is challenging due to its large size and complexity, making it both costly and labor intensive. Moreover, conventional Sanger sequencing-based genetic testing is currently limited in elucidating the causes of atypical polycystic kidney disease, such as within-family disease discordance, atypical kidney imaging patterns, and discordant disease severity between total kidney volume and rate of eGFR decline. In addition, environmental factors, genetic modifiers, and somatic mosaicism also contribute to disease variability, further limiting prognostication by mutation class in individual patients. Recent innovations in next-generation sequencing are poised to transform and extend molecular diagnostics at reasonable costs. By comprehensive screening of multiple cystic disease and modifier genes, targeted gene panel, whole-exome, or whole-genome sequencing is expected to improve both diagnostic and prognostic accuracy to advance personalized medicine in autosomal dominant polycystic kidney disease.

The Pathophysiology of Inherited Renal Cystic Diseases

Autosomal Dominant Polycystic Kidney Disease with Ectopic Unilateral Multicystic Dysplastic Kidney

Diagnosis and Management of Renal Cystic Disease of the Newborn: Core Curriculum 2021

Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies

Cystic Kidney Disease in Children

Renal Pathology of Ciliopathies

Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.

Advances in autosomal dominant polycystic kidney disease

The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians

Unusual familial cystic kidney disease: combining fine radiologic and genetic evaluation to solve the case

Glomerular Podocyte Dysfunction in Inherited Renal Tubular Disease

Signal Transduction Pathways Involved in the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease

Classification, Clinic and Hereditary of Renal Medullary Cystic Diseases

A Rare Deep Intronic Mutation of PKHD1 Gene, C.8798-459 C > A, Causes Autosomal Recessive Polycystic Kidney Disease by Pseudoexon Activation

Nephronophthisis: a pathological and genetic perspective

The Impact of Autosomal Dominant Polycystic Kidney Disease in Children: A Nephrological, Nutritional, and Psychological Point of View

Mechanistic complement of autosomal dominant polycystic kidney disease: the role of aquaporins

[Mechanisms of polycystic kidney diseases inducing male reproductive disorders].

Matching clinical and genetic data in pediatric patients at risk of developing cystic kidney disease

Polycystic Kidney Disease: Novel Insights into Polycystin Function.

Autosomal Recessive Renal Tubular Dysgenesis: Antenatal Ultrasound Scanning and Molecular Investigations.